» Articles » PMID: 36247053

Ruscogenin Protects Against Deoxynivalenol-Induced Hepatic Injury by Inhibiting Oxidative Stress, Inflammation, and Apoptosis Through the Nrf2 Signaling Pathway: An Study

Overview
Specialty General Medicine
Date 2022 Oct 17
PMID 36247053
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Deoxynivalenol (DON) is a trichothecene mycotoxin with demonstrated cytotoxicity in several cell lines and animals, primarily owing to inflammation and reactive oxygen species accumulation. Ruscogenin (RGN), a steroidal sapogenin of Radix , has significant anti-thrombotic/anti-inflammatory effects.

Objective: The aim of this study was to assess the protective role of RGN against DON-induced oxidative stress, which occurs through the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway and is regulated by phosphoinositide 3-kinases/protein kinase B (PI3K/AKT).

Methods: The effects were examined using the HepG2 cell line. RGN and DON were suspended in serum-free medium. Cells were seeded onto plates, and then RGN, DON, or both were added over 24 h in triplicates for each group.

Results: RGN conferred protection against DON-exhibited cytotoxicity against HepG2 cells. RGN pretreatment downregulated the expression of DON-induced TNF-α and COX-2 and the formation of reactive oxygen species in a dose-dependent manner. RGN upregulated the expression of Nrf2 and its antioxidant proteins as well as mRNA levels of HO-1/NQO-1/HO-1/Nrf2. Similarly, treatment with DON + RGN resulted in upregulation of the pI3K/pAKT signaling pathway in a dose-dependent manner. Finally, RGN was also found to inhibit the DON-induced apoptosis by upregulating the levels of cleaved proteins and downregulating the expression of Bcl2.

Conclusion: The study demonstrates that RGN suppresses hepatic cell injury induced by oxidative stress through Nrf2 via activation of the pI3K/AKT signaling pathway.

Citing Articles

Ruscogenin Attenuates Ulcerative Colitis in Mice by Inhibiting Caspase-1-Dependent Pyroptosis via the TLR4/NF-κB Signaling Pathway.

Li J, Wu H, Zhou J, Jiang R, Zhuo Z, Yang Q Biomedicines. 2024; 12(5).

PMID: 38790951 PMC: 11117655. DOI: 10.3390/biomedicines12050989.

References
1.
Rajendran P, Alzahrani A, Ahmed E, Veeraraghavan V . Kirenol Inhibits B[a]P-Induced Oxidative Stress and Apoptosis in Endothelial Cells via Modulation of the Nrf2 Signaling Pathway. Oxid Med Cell Longev. 2021; 2021:5585303. PMC: 8088375. DOI: 10.1155/2021/5585303. View

2.
Del Favero G, Woelflingseder L, Braun D, Puntscher H, Kutt M, Dellafiora L . Response of intestinal HT-29 cells to the trichothecene mycotoxin deoxynivalenol and its sulfated conjugates. Toxicol Lett. 2018; 295:424-437. DOI: 10.1016/j.toxlet.2018.07.007. View

3.
Li L, Yang N, Nin L, Zhao Z, Chen L, Yu J . Chinese herbal medicine formula tao hong si wu decoction protects against cerebral ischemia-reperfusion injury via PI3K/Akt and the Nrf2 signaling pathway. J Nat Med. 2014; 69(1):76-85. DOI: 10.1007/s11418-014-0865-5. View

4.
Nielsen C, Lippke H, Didier A, Dietrich R, Martlbauer E . Potential of deoxynivalenol to induce transcription factors in human hepatoma cells. Mol Nutr Food Res. 2009; 53(4):479-91. DOI: 10.1002/mnfr.200800475. View

5.
Drochner W, Schollenberger M, Gotz S, Lauber U, Tafaj M, Piepho H . Subacute effects of moderate feed loads of isolated Fusarium toxin deoxynivalenol on selected parameters of metabolism in weaned growing piglets. J Anim Physiol Anim Nutr (Berl). 2006; 90(9-10):421-8. DOI: 10.1111/j.1439-0396.2006.00622.x. View